TY - JOUR
T1 - A coordinated relocation strategy for enhancing case management of lead poisoned children
T2 - Outcomes and costs
AU - McLaine, Pat
AU - Shields, Wendy
AU - Farfel, Mark
AU - Chisolm, J. Julian
AU - Dixon, Sherry
N1 - Funding Information:
The evaluation described in this article was funded by the National Center for Healthy Housing using seed money from the Fannie Mae Foundation. The Fannie Mae Foundation, the J.C. Penney Foundation, and the U.S. Department of Housing and Urban Development provided funding for the data analysis. We thank the participating families and Program staff at the Kennedy Krieger Institute who developed and implemented this unique Program, including Michelle Warner, Veronica Kestenburg, Mary Snyder-Vogel and Cecilia Davoli, MD, of the Lead Poisoning Treatment and Prevention Program. We also thank Sandy Roda, Director of the Hematology and Environmental Laboratory, University of Cincinnati, for her assistance with quality control for lead dust testing.
PY - 2006/1
Y1 - 2006/1
N2 - Controlling residential lead hazards is critical for case management of lead poisoned children. To attain this goal, permanent relocation of the family is sometimes necessary or advisable for many reasons, including poor housing conditions; extensive lead hazards; lack of abatement resources, landlord compliance and local enforcement capacity; and family eviction. During 1996-1998, the Kennedy Krieger Institute implemented a unique capitated program for case management of Baltimore City children with blood lead concentrations (PbB) >19 μg/dL. The Program provided financial, housing, and social work assistance to facilitate relocation as a means of providing safer housing. Nearly half of the Program families relocated with direct assistance, and 28% relocated on their own. The Program evaluation examined the costs and benefits of relocation. Average relocation cost per child was relatively inexpensive (<$1,500). Average relocation time of 5 months (range <2 months to >12 months) was less than the 8-month average time to complete lead hazard control work in 14 city and state programs funded by U.S. HUD. Relocation was associated with (1) a statistically significant decrease in dust lead loadings on floors, windowsills and window troughs that persisted for one year, and (2) statistically significantly greater decreases in children's PbB compared to children who did not relocate from untreated homes. Children relocated to housing that met current Federal residential dust lead standards had statistically significant decreases in blood lead levels. Visual inspection did not consistently identify relocation houses with dust lead levels below current Federal standards, indicating that dust testing should be an essential component of future programs. This will require additional resources for dust testing and possibly cleaning and repairs but is expected to yield additional benefits for children. The findings support recent U.S. CDC case management recommendations suggesting that permanent relocation to safer housing is a viable means to reduce children's lead exposure. The benefits of relocation notwithstanding, 40% of families moved at least twice. Research is needed to better understand how to expedite relocation and encourage families to remain in safe housing. Relocation does not negate owners' and health authorities' responsibilities to address lead hazards in the child's original house in order to protect future occupants.
AB - Controlling residential lead hazards is critical for case management of lead poisoned children. To attain this goal, permanent relocation of the family is sometimes necessary or advisable for many reasons, including poor housing conditions; extensive lead hazards; lack of abatement resources, landlord compliance and local enforcement capacity; and family eviction. During 1996-1998, the Kennedy Krieger Institute implemented a unique capitated program for case management of Baltimore City children with blood lead concentrations (PbB) >19 μg/dL. The Program provided financial, housing, and social work assistance to facilitate relocation as a means of providing safer housing. Nearly half of the Program families relocated with direct assistance, and 28% relocated on their own. The Program evaluation examined the costs and benefits of relocation. Average relocation cost per child was relatively inexpensive (<$1,500). Average relocation time of 5 months (range <2 months to >12 months) was less than the 8-month average time to complete lead hazard control work in 14 city and state programs funded by U.S. HUD. Relocation was associated with (1) a statistically significant decrease in dust lead loadings on floors, windowsills and window troughs that persisted for one year, and (2) statistically significantly greater decreases in children's PbB compared to children who did not relocate from untreated homes. Children relocated to housing that met current Federal residential dust lead standards had statistically significant decreases in blood lead levels. Visual inspection did not consistently identify relocation houses with dust lead levels below current Federal standards, indicating that dust testing should be an essential component of future programs. This will require additional resources for dust testing and possibly cleaning and repairs but is expected to yield additional benefits for children. The findings support recent U.S. CDC case management recommendations suggesting that permanent relocation to safer housing is a viable means to reduce children's lead exposure. The benefits of relocation notwithstanding, 40% of families moved at least twice. Research is needed to better understand how to expedite relocation and encourage families to remain in safe housing. Relocation does not negate owners' and health authorities' responsibilities to address lead hazards in the child's original house in order to protect future occupants.
KW - Case management
KW - Childhood lead poisoning
KW - Elevated blood lead level
KW - Lead dust loading
KW - Lead interventions
KW - Relocation
UR - http://www.scopus.com/inward/record.url?scp=33745017518&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745017518&partnerID=8YFLogxK
U2 - 10.1007/s11524-005-9011-8
DO - 10.1007/s11524-005-9011-8
M3 - Article
C2 - 16736359
AN - SCOPUS:33745017518
SN - 1099-3460
VL - 83
SP - 111
EP - 128
JO - Bulletin of the New York Academy of Medicine
JF - Bulletin of the New York Academy of Medicine
IS - 1
ER -